Blackstone Results Pop on Higher Fees, Assets Under Management — Positive
BX Investopedia — July 24, 2025Blackstone (BX) shares gained after the investment management firm posted better-than-expected results and raised its dividend as fees and assets under management (AUM) took off.
Sysco's Q4 Earnings on the Horizon: What Surprise Awaits Investors? — Positive
SYY Zacks Investment Research — July 24, 2025SYY's Q4 gains likely stem from U.S. Foodservice strength, global growth moves and sharper cost efficiencies.
What's in the Cards for Arch Capital This Earnings Season? — Positive
ACGL Zacks Investment Research — July 24, 2025ACGL's Q2 results are likely to reflect rate increases, new business opportunities, growth in invested asset base, and improved pricing.
The ECB just pressed pause on rate cuts. The next move isn't clear. — Neutral
BBEU DBEF DBEU DFE EDEN EPOL EWD EWG EWI EWL EWN EWP EWQ EWU EZU FDD FEP FEZ FLGB HEDJ HEZU IEUR IEV SPEU VGK Market Watch — July 24, 2025ECB President Christine Lagarde left economists and investors a little less certain as to when, or perhaps even whether, further easing will arrive.
USANA Health Sciences is resurfacing as an idea after a strong Q2 report. The direct selling business has continued to struggle with a decline in sales and active customers. A segment turnaround remains uncertain. The previous Hiya acquisition's potential is clearly showing. Operational expansion underlines massive long-term potential for USANA.
NextEra Energy: A Dividend Aristocrat SWAN That Should Fly Higher — Positive
NEE Seeking Alpha — July 24, 2025NextEra Energy has reliably grown its payout to shareholders for 30 years. NEE also appears to be positioned for high-single-digit annual adjusted EPS growth for the foreseeable future. The company has the financial strength to capitalize on steadily growing electricity demand.
WST Stock Rises on Q2 Earnings Beat, EPS View Up on Tariff & FX Benefit — Positive
WST Zacks Investment Research — July 24, 2025West Pharmaceutical's second-quarter top line continues to benefit from revenue growth in its Proprietary Products segment.
Will lululemon's Innovation Pipeline Deliver Growth in 2H25? — Neutral
LULU Zacks Investment Research — July 24, 2025LULU bets big on technical gear and global reach to spark 2H25 growth amid cost pressures and cautious U.S. demand.
DOW Lags Q2 Earnings and Sales Estimates on Lower Prices — Negative
DOW Zacks Investment Research — July 24, 2025DOW posts a wider-than-expected Q2 loss and misses sales targets as pricing pressure and volume declines weigh on results.
Bristol Myers Gains 6.3% in a Month: Buy, Sell or Hold the Stock? — Neutral
BMY Zacks Investment Research — July 24, 2025BMY rises 6.3% in a month as investors pin hopes on new drugs to offset pressure from pipeline and patent losses.
Labcorp Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market — Positive
LH Zacks Investment Research — July 24, 2025LH tops Q2 estimates with double-digit EPS growth, margin gains and a raised 2025 outlook, lifting shares pre-market.
Molina Healthcare Q2 Earnings Miss on Rising Medical Care Costs — Negative
MOH Zacks Investment Research — July 24, 2025MOH's Q2 earnings lag estimates as rising medical care costs offset gains from premiums and rate hikes.
VANCOUVER, British Columbia and West Palm Beach, FL, July 24, 2025 (GLOBE NEWSWIRE) -- AgriFORCE Growing Systems Ltd. (“the Company”) (NASDAQ: AGRI) today announced the Company's Board of Directors has approved a reverse stock split of the Company's issued and outstanding common shares whereby every nine (9) shares of its outstanding common shares will automatically be combined into one (1) common share. The reverse split was approved by the Company's shareholders on June 6, 2025 and will be effective as of the commencement of trading on July 28, 2025 at the open of market. As of the close of business …
Texas Instruments Q2 Earnings: Solid Quarter, Still Waiting For A Better Entry Point — Positive
TXN Seeking Alpha — July 24, 2025Texas Instruments Incorporated delivered a solid quarter, with sequential revenue growth and better working capital management, but geopolitical risks and tariffs remain a concern. Management acknowledges some Q2 strength was likely demand pulled forward due to tariffs, and industrial recovery is more robust than automotive. Valuation has run ahead of fundamentals, with the stock trading at a premium not fully justified by current earnings or margin outlook.
Deal-making is likely to rebound in back-half of 2025, says Lazard CEO Peter Orszag — Neutral
LAZ CNBC Television — July 24, 2025Peter Orszag, Lazard CEO, joins 'Money Movers' to discuss Q2 earnings, dealmaking and business in Europe.
CenterPoint Energy Q2 Earnings Miss Estimates, Revenues Improve Y/Y — Negative
CNP Zacks Investment Research — July 24, 2025CNP's Q2 earnings fell short of estimates on higher financing costs, but revenues rose 2% year over year to $1.94 billion.
Top Drone Tech Stocks to Add to Your Portfolio for Strong Returns — Positive
DPRO ONDS UMAC Zacks Investment Research — July 24, 2025ONDS, DPRO and UMAC are some stocks in the drone technology space that are worthy of investment consideration.
Large-Cap ETF (SCHX) Hits a New 52-Week High — Positive
SCHX Zacks Investment Research — July 24, 2025SCHX surges to a new 52-week high, up 32.2% from its low, driven by market momentum and sector strength.
VKTX Stock Down on Wider-Than-Expected Loss in Q2, Nil Sales — Negative
VKTX Zacks Investment Research — July 24, 2025Shares of Viking slide after Q2 loss widens to 58 cents per share on rising R&D and nil revenues, missing estimates by 14 cents.
ACNB (ACNB) came out with quarterly earnings of $1.11 per share, missing the Zacks Consensus Estimate of $1.14 per share. This compares to earnings of $1.32 per share a year ago.
